Koru Medical Systems, Inc. KRMD

Q2 FY2026 · ended Jun 30, 2026 · Revenue $12.05M, +18.2% YoY · Filed Aug 5, 2026

Koru Medical Systems, Inc. (KRMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $12.0 million and net income of $252,449. Free cash flow was $108,206. As of Jun 30, 2026 it held $8.3 million in cash and investments and $3.3 million in total debt.

Revenue
$12.05M
+18.2% vs year-ago quarter
Net income
$252,449
+222.0% vs year-ago quarter
Operating cash flow
$216,113
+146.9% vs year-ago quarter
Free cash flow
$108,206
+122.1% vs year-ago quarter
EPS
$0.01
Dividend per share
None
Shares outstanding
46.17M
-0.1% vs year-ago quarter
Net cash
$4.98M
Q2 FY2026
Operating margin
-3.7%
TTM

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
KRMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Mahwah, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
704440
Former names
REPRO MED SYSTEMS INC (until Jun 3, 2022)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$12.0M
$11.8M
$10.9M
$10.4M
$10.2M
Operating income
$626,991
-$864,923
-$547,104
-$867,679
-$312,655
Net income
$252,449
-$807,078
-$486,856
-$777,966
-$206,867
Diluted EPS
$0.01
-$0.02
-$0.01
$0.02
$0.00
Operating cash flow
$216,113
$14,663
$1.1M
$65,456
-$460,340
Free cash flow
$108,206
-$31,500
$686,974
$12,973
-$489,154
Total assets
$28.0M
$28.6M
$28.2M
$27.1M
$25.5M
Total liabilities
$9.9M
$11.7M
$11.2M
$10.6M
$9.0M
Stockholders' equity
$18.1M
$16.9M
$17.0M
$16.5M
$16.5M
Cash and investments
$8.3M
$8.8M
$8.9M
$8.5M
$8.1M
Total debt
$3.3M
$3.4M
$3.5M
$3.3M
$3.5M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Bylaw or fiscal year change
Aug 14, 2026 Aug 13, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement
Jun 30, 2026 Jun 24, 2026
8-K Current report
Shareholder vote results
May 21, 2026 May 19, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.